Key Laboratory of Food Nutrition and Functional Food of Hainan Province, School of Food Science and Engineering, Hainan University, Haikou 570228, China.
Collaborative Innovation Center of Provincial and Ministerial Co-Construction for Marine Food Deep Processing, Dalian Polytechnic University, Dalian 116034, China.
Int J Mol Sci. 2023 Jan 29;24(3):2553. doi: 10.3390/ijms24032553.
A vital bioactive component of marine resources is polysaccharides (HLP). This study examined whether HLP could regulate intestinal flora to treat loperamide-induced constipation. Constipated mice showed signs of prolonged defecation (up by 60.79 min) and a reduced number of bowel movements and pellet water content (decreased by 12.375 and 11.77%, respectively). The results showed that HLP treatment reduced these symptoms, reversed the changes in related protein expression levels in the colon, and regulated the levels of active peptides associated with the gastrointestinal tract in constipated mice, which significantly improved water-electrolyte metabolism and enhanced gastrointestinal motility. Meanwhile, it was found that intestinal barrier damage was reduced and the inflammatory response was inhibited through histopathology and immunohistochemistry. As a means to further relieve constipation symptoms, treatment with low, medium, and high HLP concentrations increased the total short-chain fatty acid (SCFA) content in the intestine of constipated mice by 62.60 μg/g, 138.91 μg/g, and 126.51 μg/g, respectively. Moreover, an analysis of the intestinal flora's gene for 16S rRNA suggested that the intestinal microbiota was improved through HLP treatment, which is relevant to the motivation for the production of SCFAs. In summary, it was demonstrated that HLP reduced loperamide-induced constipation in mice.
海洋资源中的一种重要生物活性成分是多糖(HLP)。本研究探讨了 HLP 是否可以通过调节肠道菌群来治疗洛哌丁胺诱导的便秘。便秘小鼠表现出排便时间延长(增加 60.79 分钟)、排便次数和粪便含水量减少(分别减少 12.375%和 11.77%)的迹象。结果表明,HLP 治疗可减轻这些症状,逆转结肠中相关蛋白表达水平的变化,并调节便秘小鼠与胃肠道相关的活性肽水平,从而显著改善水-电解质代谢,增强胃肠蠕动。同时,通过组织病理学和免疫组织化学发现,肠道屏障损伤减轻,炎症反应受到抑制。作为进一步缓解便秘症状的一种手段,低、中、高浓度 HLP 处理分别使便秘小鼠肠道内总短链脂肪酸(SCFA)含量增加了 62.60μg/g、138.91μg/g 和 126.51μg/g。此外,对 16S rRNA 肠道菌群基因的分析表明,HLP 处理改善了肠道微生物群,这与 SCFA 产生的动力有关。综上所述,研究表明 HLP 可减轻洛哌丁胺诱导的小鼠便秘。